Autolus Therapeutics EPS Diluted from Accounting Change (Quarterly) Analysis

Autolus Therapeutics Plc (AUTL)

1.765 -0.06 (-3.02%) USD | NASDAQ | Feb 25, 16:00

1.765 0.00 (0.00%) After-Hours: 17:25

View EPS Diluted from Accounting Change (Quarterly) for AUTL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Accounting Change (Quarterly) Benchmarks

Start Trial

Biodexa Pharmaceuticals Plc	--
NuCana Plc	--
Mereo BioPharma Group Plc	--
Bicycle Therapeutics Plc	--
DBV Technologies SA	--